Authors

• Michael Warwick‐Sanders
• David Dorey
• Sergio Lupo
• Viviana Wilches
• Marisa Sánchez
• Paul Benson
• Marina B. Klein (ORCID: https://orcid.org/0000-0002-3063-8430)
• Ralph B. D’Agostino (ORCID: https://orcid.org/0000-0002-3550-8395)
• Christopher Bettacchi
• Christina Donatti
• Joseph P. McGowan (ORCID: https://orcid.org/0000-0003-1120-7085)
• Charlotte-Paige Rolle (ORCID: https://orcid.org/0000-0002-6444-2225)
• Pedro Cahn (ORCID: https://orcid.org/0000-0002-9381-1931)
• Paul Wannamaker
• Rulan Griesel (ORCID: https://orcid.org/0000-0003-3633-2878)
• Yash Gandhi (ORCID: https://orcid.org/0000-0001-7637-9617)
• Jan Losos
• Kathryn Brown (ORCID: https://orcid.org/0000-0002-4999-8145)
• Margaret Gartland (ORCID: https://orcid.org/0000-0002-1200-3706)
• Stefan Schneider (ORCID: https://orcid.org/0000-0002-4562-0524)
• A. Ferro
• Peter A. Leone

Institutions

• Northwell Health (US)
• McGill University Health Centre (CA)
• Hurley Medical Center (US)
• Hospital Italiano de Buenos Aires (AR)
• National University of Rosario (AR)
• Infectious Disease Consultants (US)
• ViiV Healthcare (United Kingdom) (GB)
• Fundación Huésped (AR)
• GlaxoSmithKline (United States) (US)
• Certara (United States) (US)
• Orlando Immunology Center (US)
• GlaxoSmithKline (Canada) (CA)
• Southern California Institute for Research and Education (US)
• Centro de Investigaciones Cardiovasculares (AR)
• Centro Científico Tecnológico Mar del Plata (AR)
• California State University, Long Beach (US)

Publication Details

Journal

The Journal of Infectious Diseases

Published

2025-08-30

DOI

https://doi.org/10.1093/infdis/jiaf450

Primary Topic

HIV/AIDS drug development and treatment

Type

article

Field-Weighted Citation Impact

0.00

Funders

• ViiV Healthcare